BNB Treasury Hype Turns Sour: Nasdaq To Delist Windtree Therapeutics After Stock Falls To Just 11 Cents
Windtree is being delisted from Nasdaq after its share price crashed below the required $1 level. The company’s shift from biotech to holding BNB tokens failed to win investor trust, wiping out nearly all its value.
